A citation-based method for searching scientific literature

Bhuvic Patel, Rukayat Taiwo, Albert H Kim, Gavin P Dunn. Neurooncol Adv 2020
Times Cited: 7







List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
42

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017
439
42

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
848
28

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
28

A DNA damage checkpoint response in telomere-initiated senescence.
Fabrizio d'Adda di Fagagna, Philip M Reaper, Lorena Clay-Farrace, Heike Fiegler, Philippa Carr, Thomas Von Zglinicki, Gabriele Saretzki, Nigel P Carter, Stephen P Jackson. Nature 2003
28

Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
28

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
28

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
28

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET.
Elena K Bauer, Gabriele Stoffels, Tobias Blau, Guido Reifenberger, Jörg Felsberg, Jan M Werner, Philipp Lohmann, Jurij Rosen, Garry Ceccon, Caroline Tscherpel,[...]. Eur J Nucl Med Mol Imaging 2020
4
50

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Nathalie L Albert, Michael Weller, Bogdana Suchorska, Norbert Galldiks, Riccardo Soffietti, Michelle M Kim, Christian la Fougère, Whitney Pope, Ian Law, Javier Arbizu,[...]. Neuro Oncol 2016
293
28

Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
Nathalie L Jansen, Bogdana Suchorska, Vera Wenter, Sabina Eigenbrod, Christine Schmid-Tannwald, Andreas Zwergal, Maximilian Niyazi, Mark Drexler, Peter Bartenstein, Oliver Schnell,[...]. J Nucl Med 2014
83
28

Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?
Marcus Unterrainer, Franziska Vettermann, Matthias Brendel, Adrien Holzgreve, Michael Lifschitz, Matthias Zähringer, Bogdana Suchorska, Vera Wenter, Ben M Illigens, Peter Bartenstein,[...]. EJNMMI Res 2017
39
28

Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma.
Nathalie L Jansen, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Andrei Todica, Sabina Eigenbrod, Maximilian Niyazi, Jörg-Christian Tonn, Peter Bartenstein, Friedrich-Wilhelm Kreth,[...]. J Nucl Med 2015
91
28

Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma.
Bogdana Suchorska, Armin Giese, Annamaria Biczok, Marcus Unterrainer, Michael Weller, Mark Drexler, Peter Bartenstein, Ulrich Schüller, Jörg-Christian Tonn, Nathalie L Albert. Neuro Oncol 2018
39
28

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.
Dirk Pauleit, Frank Floeth, Kurt Hamacher, Markus J Riemenschneider, Guido Reifenberger, Hans-Wilhelm Müller, Karl Zilles, Heinz H Coenen, Karl-Josef Langen. Brain 2005
387
28

Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
Marcus Unterrainer, Florian Schweisthal, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Wolfgang P Fendler, Ulrich Schüller, Peter Bartenstein, Jörg-Christian Tonn, Nathalie L Albert. J Nucl Med 2016
36
28

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.
Norbert Galldiks, Marcus Unterrainer, Natalie Judov, Gabriele Stoffels, Marion Rapp, Philipp Lohmann, Franziska Vettermann, Veronika Dunkl, Bogdana Suchorska, Jörg C Tonn,[...]. Neuro Oncol 2019
12
28

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
14

Platform trials arrive on time for glioblastoma.
Brian M Alexander, Timothy F Cloughesy. Neuro Oncol 2018
7
14

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Eric Bouffet, Valérie Larouche, Brittany B Campbell, Daniele Merico, Richard de Borja, Melyssa Aronson, Carol Durno, Joerg Krueger, Vanja Cabric, Vijay Ramaswamy,[...]. J Clin Oncol 2016
428
14

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, Sevin Turcan, Christian Grommes, Carl Campos, Jennifer Tsoi, Owen Clark, Barbara Oldrini, Evangelia Komisopoulou,[...]. Science 2013
738
14

Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas.
Mirco Friedrich, Lukas Bunse, Wolfgang Wick, Michael Platten. Curr Opin Oncol 2018
7
14


Telomerase activity and alterations in telomere length in human brain tumors.
S Hiraga, T Ohnishi, S Izumoto, E Miyahara, Y Kanemura, H Matsumura, N Arita. Cancer Res 1998
111
14

Mechanisms and therapeutic implications of hypermutation in gliomas.
Mehdi Touat, Yvonne Y Li, Adam N Boynton, Liam F Spurr, J Bryan Iorgulescu, Craig L Bohrson, Isidro Cortes-Ciriano, Cristina Birzu, Jack E Geduldig, Kristine Pelton,[...]. Nature 2020
101
14

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
14

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.
Jayne M Stommel, Alec C Kimmelman, Haoqiang Ying, Roustem Nabioullin, Aditya H Ponugoti, Ruprecht Wiedemeyer, Alexander H Stegh, James E Bradner, Keith L Ligon, Cameron Brennan,[...]. Science 2007
678
14

Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.
Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Junji Shibahara, Yusuke Tabei, Kazuhide Furuya, Takafumi Ide, Yoshitaka Narita, Ryo Nishikawa, Keisuke Ueki,[...]. Cancer Sci 2012
67
14

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.
Daniel P Cahill, Kymberly K Levine, Rebecca A Betensky, Patrick J Codd, Candice A Romany, Linsey B Reavie, Tracy T Batchelor, P Andrew Futreal, Michael R Stratton, William T Curry,[...]. Clin Cancer Res 2007
270
14

N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.
Wolfgang Wick, Susan Dettmer, Anne Berberich, Tobias Kessler, Irini Karapanagiotou-Schenkel, Antje Wick, Frank Winkler, Elke Pfaff, Benedikt Brors, Jürgen Debus,[...]. Neuro Oncol 2019
37
14

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Michail S Lionakis, Kieron Dunleavy, Mark Roschewski, Brigitte C Widemann, John A Butman, Roland Schmitz, Yandan Yang, Diane E Cole, Christopher Melani, Christine S Higham,[...]. Cancer Cell 2017
210
14

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.
Paul H Huang, Akitake Mukasa, Rudy Bonavia, Ryan A Flynn, Zachary E Brewer, Webster K Cavenee, Frank B Furnari, Forest M White. Proc Natl Acad Sci U S A 2007
290
14

Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
Peter J Cook, Rozario Thomas, Ram Kannan, Esther Sanchez de Leon, Alexander Drilon, Marc K Rosenblum, Maurizio Scaltriti, Robert Benezra, Andrea Ventura. Nat Commun 2017
34
14

Blood-brain barrier delivery.
William M Pardridge. Drug Discov Today 2007
644
14

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Genevieve Schindler, David Capper, Jochen Meyer, Wibke Janzarik, Heymut Omran, Christel Herold-Mende, Kirsten Schmieder, Pieter Wesseling, Christian Mawrin, Martin Hasselblatt,[...]. Acta Neuropathol 2011
638
14

Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence.
Akitake Mukasa, Jill Wykosky, Keith L Ligon, Lynda Chin, Webster K Cavenee, Frank Furnari. Proc Natl Acad Sci U S A 2010
50
14

Longitudinal molecular trajectories of diffuse glioma in adults.
Floris P Barthel, Kevin C Johnson, Frederick S Varn, Anzhela D Moskalik, Georgette Tanner, Emre Kocakavuk, Kevin J Anderson, Olajide Abiola, Kenneth Aldape, Kristin D Alfaro,[...]. Nature 2019
99
14

An integrated genomic analysis of human glioblastoma multiforme.
D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia,[...]. Science 2008
14

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.
Gang Wu, Alexander K Diaz, Barbara S Paugh, Sherri L Rankin, Bensheng Ju, Yongjin Li, Xiaoyan Zhu, Chunxu Qu, Xiang Chen, Junyuan Zhang,[...]. Nat Genet 2014
545
14

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.
Andrea Sottoriva, Inmaculada Spiteri, Sara G M Piccirillo, Anestis Touloumis, V Peter Collins, John C Marioni, Christina Curtis, Colin Watts, Simon Tavaré. Proc Natl Acad Sci U S A 2013
934
14

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
14


Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
Andrew S Chi, Rohinton S Tarapore, Matthew D Hall, Nicole Shonka, Sharon Gardner, Yoshie Umemura, Ashley Sumrall, Ziad Khatib, Sabine Mueller, Cassie Kline,[...]. J Neurooncol 2019
39
14

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts.
Masamichi Takahashi, Shunichiro Miki, Kenji Fujimoto, Kohei Fukuoka, Yuko Matsushita, Yoshiko Maida, Mami Yasukawa, Mitsuhiro Hayashi, Raku Shinkyo, Kiyomi Kikuchi,[...]. Cancer Sci 2019
16
14

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.
David T W Jones, Sylvia Kocialkowski, Lu Liu, Danita M Pearson, L Magnus Bäcklund, Koichi Ichimura, V Peter Collins. Cancer Res 2008
540
14

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.
Philip Jonsson, Andrew L Lin, Robert J Young, Natalie M DiStefano, David M Hyman, Bob T Li, Michael F Berger, Ahmet Zehir, Marc Ladanyi, David B Solit,[...]. Clin Cancer Res 2019
38
14

Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor.
Christopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, Corey M Gill, Andrew Kaneb, Megan D'Andrea, Long P Le, Jesse Lee, Ju Cheng, Zongli Zheng,[...]. NPJ Precis Oncol 2017
33
14


H3F3A K27M mutations in thalamic gliomas from young adult patients.
Koki Aihara, Akitake Mukasa, Kengo Gotoh, Kuniaki Saito, Genta Nagae, Shingo Tsuji, Kenji Tatsuno, Shogo Yamamoto, Shunsaku Takayanagi, Yoshitaka Narita,[...]. Neuro Oncol 2014
104
14

Distinct molecular profile of diffuse cerebellar gliomas.
Masashi Nomura, Akitake Mukasa, Genta Nagae, Shogo Yamamoto, Kenji Tatsuno, Hiroki Ueda, Shiro Fukuda, Takayoshi Umeda, Tomonari Suzuki, Ryohei Otani,[...]. Acta Neuropathol 2017
21
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.